Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 65862-187

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 65862-187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (4 mg Blister Carton (10 x 10 Unit-dose))
This is a description for Ondansetron Tablets, USP, indicated for use by prescription only. The tablets, manufactured by Aurobindo Pharma USA, are film-coated and contain 4 mg of ondansetron hydrochloride USP. Dispensation should take place in light-resistant containers in accordance with the USP. Dosage and administration instructions are available in the package insert. The tablets should be protected from light and stored at a temperature between 20° to 25°C.*
FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (4 mg Blister Carton (10 x 10 Unit-dose))
This appears to be a label of medication - Ondansetron Tablets, USP, with its dosage information and drug manufacturer details. It also mentions some unreadable text and the drug's NDC code (65862-187-10).*
FDA Label Image

Package Label-principal Display Panel (8 mg (500 Tablet Bottle))

Package Label-principal Display Panel (8 mg (500 Tablet Bottle))
This is a description of Ondansetron Tablets, USP manufactured by Aurobindo. Each tablet contains Ondansetron hydrochloride USP dihydrate equivalent to 8mg of Ondansetron. Usual dosage must be checked on the package insert for dosage and administration. Dispense in a tight, light-resistant container as defined in the USP. It is advised to store in between 20-25°C with excursions permitted to 15-30°C. Users should protect it from light. There is an over printing zone coding area that is not to be printed.*
FDA Label Image

Package Label-principal Display Panel (8 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (8 mg Blister Carton (10 x 10 Unit-dose))
This is a product label for Ondansetron Tablets, USP, manufactured by Aurobindo. The code NDC 65862-188-10 is displayed, which is likely a product identification number. The tablets are available by prescription only and come in a package of 100 tablets. There are additional unreadable characters and symbols that do not contribute to the description.*
FDA Label Image

Package Label-principal Display Panel (24 mg Blister Carton (1 x 1 Unit-dose))

Package Label-principal Display Panel (24 mg Blister Carton (1 x 1 Unit-dose))
Ondansetron Tablet, USP is a prescription drug with NDC 65862-189-11. The drug is manufactured by Aurobindo. The text also contains irrelevant characters that do not provide any useful information.*
FDA Label Image

Chemical Structure (Ondansetron Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.